AR and prostate neoplasm: However, since subcutaneous xenografts cannot fully recapitulate the natural progression of PCa, we employed an orthotopic prostate tumor model using RM-1 cells to utilize the mice's endogenous androgen secretion system, thereby dynamically mimicking AR signaling activation patterns in clinical patients.